Clinical Trial Update: Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial at Yale University is evaluating physiologic markers of cardiometabolic risk in people with type 1 diabetes and obesity and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Yale University | Conditions: type1diabetes, Obesity | Phase 1 | Status: RECRUITING